StemCells (STEM) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq slides to near one-month low as AI rout deepens
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $3.58 -0.28%
Revenue Growth %: +5.6%
Financial Fact:
Total operating expenses: 8.91M
Today's EPS Names:
NTRP, FMCB, LOOP, More
Revenue Growth %: +5.6%
Financial Fact:
Total operating expenses: 8.91M
Today's EPS Names:
NTRP, FMCB, LOOP, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $883 million versus the consensus estimate of $220 million.
For earnings history and earnings-related data on StemCells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues
- TD Cowen on Establishment Labs Inc. (ESTA): 'The Selloff Looks Overdone as a Major FDA Catalyst Approaches'
- Slew of analyst comments sends Take-Two (TTWO) up 4% ahead of November earnings and GTV 6
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
